Dawei Chen
Liege, WAL 4000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Longitudinal single-cell RNA sequencing reveals a heterogeneous response of plasma cells to colonic inflammation.
Journal: International journal of biological macromolecules
Published: August 27, 2024
Regulatory CD4+ T cells redirected against pathogenic CD8+ T cells protect NOD mice from development of autoimmune diabetes.
Journal: Frontiers in immunology
Published: July 12, 2024
Oxytocin Alleviates Colitis and Colitis-Associated Colorectal Tumorigenesis via Noncanonical Fucosylation.
Journal: Research (Washington, D.C.)
Published: February 08, 2024
Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice.
Journal: Frontiers in immunology
Published: May 22, 2023
m6A Regulator-Based Exosomal Gene Methylation Modification Patterns Identify Distinct Microenvironment Characterization and Predict Immunotherapeutic Responses in Colon Cancer.
Journal: Oxidative medicine and cellular longevity
Published: March 27, 2022
Inhibition of GABAA receptors in intestinal stem cells prevents chemoradiotherapy-induced intestinal toxicity.
Journal: The Journal of experimental medicine
Published: March 26, 2022
Reply to the Comment on "The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ".
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 13, 2022
A Real-Time EMG-Based Fixed-Bandwidth Frequency-Domain Embedded System for Robotic Hand.
Journal: Frontiers in neurorobotics
Published: February 21, 2022
Tumor Microenvironment Shapes Colorectal Cancer Progression, Metastasis, and Treatment Responses.
Journal: Frontiers in medicine
Published: February 03, 2022
Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia.
Journal: Leukemia
Published: January 24, 2022
Deacetylation of YAP1 Promotes the Resistance to Chemo- and Targeted Therapy in FLT3-ITD+ AML Cells.
Deacetylation of YAP1 Promotes the Resistance to Chemo- and Targeted Therapy in FLT3-ITD+ AML Cells.
Journal: Frontiers in cell and developmental biology
Published: December 23, 2021
Thymic B Cells as a New Player in the Type 1 Diabetes Response.
Journal: Frontiers in immunology
Published: September 07, 2021
Last Updated: 09/26/2026